Clinical Trial Detail

NCT ID NCT03297606
Title Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) (CAPTUR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Canadian Cancer Trials Group
Indications

Advanced Solid Tumor

non-Hodgkin lymphoma

multiple myeloma

Therapies

Bosutinib

Palbociclib

Vismodegib

Ipilimumab + Nivolumab

Cobimetinib + Vemurafenib

Temsirolimus

Olaparib

Erlotinib

Crizotinib

Sunitinib

Afatinib

Dasatinib

Pertuzumab + Trastuzumab

Axitinib

Age Groups: adult senior

Additional content available in CKB BOOST